Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

CHINESE soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of 2025, ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

More jumbo stock offerings from some of China’s biggest onshore-listed companies are making their way to Hong Kong, supported ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

Hong Kong Pharma Digital Technology Holdings Limited (HKPD, Financials) plummeted 29.5% to close as of 8:00 a.m. ET at $2.82 ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...